• 1. Acetyl protected thiol methacrylic polymers as effective ligands to keep quantum dots in luminescent standby mode?
  Marta Liras,Isabel Quijada-Garrido,Marta Palacios-Cuesta,Sonia Mu?oz-Durieux,Olga García Polym. Chem., 2014,5, 433-442
• 2. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 5. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Amino fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Amino fatty acids

Comprehensive Overview of 4-(Dimethylamino)-4-phenylbutanoic acid (CAS No. 1481264-52-1): Properties, Applications, and Research Insights

4-(Dimethylamino)-4-phenylbutanoic acid (CAS No. 1481264-52-1) is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its unique dimethylamino and phenyl functional groups, serves as a versatile intermediate in synthetic chemistry. Its molecular structure, C12H17NO2, offers a balance of hydrophobicity and reactivity, making it valuable for designing novel drug candidates and studying neurotransmitter analogs.

In recent years, the demand for 4-(dimethylamino)-4-phenylbutanoic acid has surged due to its potential role in central nervous system (CNS) drug development. Researchers are exploring its derivatives for applications in neurological disorders, such as Parkinson's disease and depression, aligning with the growing public interest in mental health therapeutics. The compound's butanoic acid backbone also makes it a candidate for prodrug formulations, a hot topic in targeted drug delivery systems.

From a synthetic perspective, CAS No. 1481264-52-1 is often synthesized via Michael addition reactions or reductive amination, methods frequently searched by organic chemists. Its logP value and pKa are critical parameters for ADME (Absorption, Distribution, Metabolism, Excretion) studies, a key focus area in pharmacokinetics. These properties are frequently queried in academic databases, reflecting the compound's relevance in medicinal chemistry.

The compound's phenylbutanoic acid moiety shares structural similarities with nonsteroidal anti-inflammatory drugs (NSAIDs), sparking interest in its potential anti-inflammatory applications. This connection resonates with current trends in natural product-inspired drug discovery, a popular subject in Google Scholar and PubMed searches. Additionally, its dimethylamino group enables interactions with G-protein-coupled receptors (GPCRs), a target class dominating biopharmaceutical research.

Quality control of 4-(dimethylamino)-4-phenylbutanoic acid relies on advanced analytical techniques like HPLC and LC-MS, terms highly searched by quality assurance professionals. The compound's stability under various pH conditions and thermal degradation profiles are also critical for industrial-scale production, addressing common queries in process chemistry forums.

In summary, CAS No. 1481264-52-1 represents a multifaceted tool for researchers exploring neuroactive compounds, prodrug design, and small-molecule therapeutics. Its intersection with trending topics like precision medicine and AI-driven drug discovery ensures its continued relevance in scientific literature and patent filings.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)